Cyclic guanosine monophosphate as a mediator of vasodilation.
Murad
F
F
D001386:Azides / Q000494:pharmacology; D006152:Cyclic GMP / Q000502:physiology*; D004727:Endothelium / Q000187:drug effects; D004789:Enzyme Activation; D020558:GTP Phosphohydrolases / Q000037:antagonists & inhibitors; D006160:Guanosine Triphosphate / Q000378:metabolism; D006162:Guanylate Cyclase / Q000378:metabolism; D006207:Half-Life; D006863:Hydrogen-Ion Concentration; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D008954:Models, Biological; D008970:Molecular Weight; D009126:Muscle Relaxation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009569:Nitric Oxide; D009599:Nitroprusside / Q000494:pharmacology; D010100:Oxygen; D011494:Protein Kinases / Q000378:metabolism; D014664:Vasodilation; D014665:Vasodilator Agents / Q000302:isolation & purification
D001386:Azides; D007527:Isoenzymes; D014665:Vasodilator Agents; D009599:Nitroprusside; D009569:Nitric Oxide; D006160:Guanosine Triphosphate; D011494:Protein Kinases; D020558:GTP Phosphohydrolases; D006162:Guanylate Cyclase; D006152:Cyclic GMP; D010100:Oxygen